Showing results (131-140 of 151) with videos related to

Sort By:
Pageof 16
Cancers|February 11, 2021
Quantification and Optimization of Standard-of-Care Therapy to Delay the Emergence of Resistant Bone Metastatic Prostate CancerArturo Araujo, Leah M Cook, Jeremy S Frieling, et al.
Nature Ecology & Evolution|January 19, 2021
Spontaneous cell fusions as a mechanism of parasexual recombination in tumour cell populationsDaria Miroshnychenko, Etienne Baratchart, Meghan C Ferrall-Fairbanks, et al.
Plos Computational Biology|March 11, 2020
Hybrid Automata Library: A flexible platform for hybrid modeling with real-time visualizationRafael R Bravo, Etienne Baratchart, Jeffrey West, et al.
Biorxiv : the Preprint Server for Biology|January 8, 2024
Branched-chain keto acids promote an immune-suppressive and neurodegenerative microenvironment in leptomeningeal diseaseMariam Lotfy Khaled, Yuan Ren, Ronak Kundalia, et al.
Elife|March 23, 2023
A survey of open questions in adaptive therapy: Bridging mathematics and clinical translationJeffrey West, Fred Adler, Jill Gallaher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 10, 2022
Combination Nivolumab, CD137 Agonism, and Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes for Patients with Metastatic MelanomaMacLean S Hall, John E Mullinax, Cheryl A Cox, et al.
Biorxiv : the Preprint Server for Biology|May 7, 2024
Peristromal niches protect lung cancers from targeted therapies through a combined effect of multiple molecular mediatorsBina Desai, Tatiana Miti, Sandhya Prabhakaran, et al.
Biorxiv : the Preprint Server for Biology|October 28, 2024
Nanoparticles use magnetoelectricity to target and eradicate cancer cellsJohn Michael Bryant, Emmanuel Stimphil, Victoria Andre, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 3, 2025
Magnetoelectric Nanotherapy Achieves Complete Tumor Ablation and Prolonged Survival in Pancreatic Cancer Murine ModelsJohn Michael Bryant, Max Shotbolt, Emmanuel Stimphil, et al.
Immunity|April 16, 2020
The Unfolded Protein Response Mediator PERK Governs Myeloid Cell-Driven Immunosuppression in Tumors through Inhibition of STING SignalingEslam Mohamed, Rosa A Sierra, Jimena Trillo-Tinoco, et al.
Pageof 16